1.
Tamez-Pérez HE, SUMER G de E. Efficacy and safety of inicitial treatment with glimpeiride versus sitagliptin in type 2 diabetes. Rev Med Inst Mex Seguro Soc [Internet]. 2015 Feb. 6 [cited 2026 Nov. 16];53(2):142-8. Available from: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/4